![](/img/cover-not-exists.png)
An exploratory case study of the impact of expanding cost-effectiveness analysis for second-line nivolumab for patients with squamous non-small cell lung cancer in Canada: Does it make a difference?
Shafrin, Jason, Skornicki, Michelle, Brauer, Michelle, Villeneuve, Julie, Lees, Michael, Hertel, Nadine, Penrod, John R., Jansen, JeroenLanguage:
english
Journal:
Health Policy
DOI:
10.1016/j.healthpol.2018.04.008
Date:
April, 2018
File:
PDF, 731 KB
english, 2018